JDRF nPOD 8th Annual Scientific Meeting
February 21-24, 2016
Miami Marriott Biscayne Bay
1633 North Bayshore Drive, Miami, FL 33132
Please do NOT contact the hotel direct. Your registration form will take the place of making your reservation.
We encourage each nPOD Investigator to submit abstracts of research utilizing nPOD resources. Deadline for abstract submission is October 15th, 2015. Please contact Amanda Myers should you need assistance in submitting abstract.
Our scientists are not locatedin one lab,on one campus,or in one country…
We are united in one goal, to cure type 1 diabetes.
Helmsley Cellular Research Hub
The Helmsley Cellular Research Hub was established as part of a type 1 diabetes coalition comprised of the Naomi Berrie Diabetes Center at Columbia University, the New York Stem Cell Foundation and the University of Florida Diabetes Institute, with funding support from The Leona M. and Harry B. Helmsley Charitable Trust. The goal of the Helmsley Cellular Research Hub is to promote a greater understanding of type 1 diabetes and accelerate new potential therapies to treat the disease.
Thanks to the support of the Helmsley Charitable Trust, a number of somatic and pluripotent cell lines obtained from well-phenotyped type 1 diabetes patients and suitable controls/patients with other forms of diabetes are now available to qualified research scientists.
Find more information here.
nPOD Publications Reach 100
Dr. Martha Campbell-Thompson recently published the 100th nPOD publication: Organ donor specimens: What can they tell us about type 1 diabetes? Pediatric Diabetes 2015:16:320-330.
“This mini-review will provide some key histopathological findings emanating from the nPOD collection, including the heterogeneity of beta cell loss and islet inflammation (or insulitis, shown in the image to the right), beta cell mass, insulin-producing beta cells in chronic T1D, and pancreas weight reductions at disease onset. Analysis of variations in histopathology observed from these organ donors could provide for mechanistic differences related to etiological agents and serve an important function in terms of identifying the heterogeneity of T1D.”
Director of the Institute of Biomedical and Clinical Science, University of Exeter Medical School
The JDRF-nPOD Scientists Who Seek the Cure for T1D
Each month, we highlight one of the nPOD investigators. Thanks to the fundraising of all the JDRF chapters, these scientists are able to have access to nPOD samples for their work. We’ll let them introduce themselves, tell you about their research, and their lives.